30
Participants
Start Date
July 15, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
CD70-targeting CAR-T cells
"Dose escalation:~Dose1 (1×10\^6 cells/kg) , Dose 2(3×10\^6 cells/kg) ,Dose 3 (1×10\^7cells/kg);~Dose expansion: RP2D~Drug: Albumin-bound paclitaxel~Administered intravenously at dose of 100-200mg/m2 on day -5;~Drug: Cyclophosphamide~Administered intravenously at dose of 15-30mg/kg on day -3 and day -2;~Drug: Fludarabine~Administered intravenously at dose of 30mg/m2 on day -3 and day -2;"
RECRUITING
China, Beijing
UTC Therapeutics Inc.
INDUSTRY
Chinese PLA General Hospital
OTHER